(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 5.04% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Bausch & Lomb's revenue in 2025 is $4,976,000,000.On average, 17 Wall Street analysts forecast BLCO's revenue for 2025 to be $1,833,994,701,552, with the lowest BLCO revenue forecast at $1,754,656,189,936, and the highest BLCO revenue forecast at $1,897,040,483,104. On average, 17 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,939,897,446,968, with the lowest BLCO revenue forecast at $1,838,953,358,528, and the highest BLCO revenue forecast at $2,022,069,476,856.
In 2027, BLCO is forecast to generate $2,041,904,104,760 in revenue, with the lowest revenue forecast at $1,921,125,388,416 and the highest revenue forecast at $2,143,556,572,768.